Jiangong Shi
State Key Laboratory Of Bioactive Substance And Function Of Natural Medicines, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Benzyl sulfide, sulfoxide and sulfinate metabolites from Gastrodia elata and their synthesis, derivatization and anti-inflammatory activity.
Journal: Chinese journal of natural medicines
Published: January 09, 2025
A synthetic derivative of bioactive constituents from Isatis indigotica ameliorates hypersensitivity and arthritis by inhibiting JAK2-STAT3 pathway in mice.
Journal: International immunopharmacology
Published: June 02, 2023
Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug targets.
Journal: Acta pharmaceutica Sinica. B
Published: August 05, 2022
Base-Promoted Formal [3 + 2] Cycloaddition of α-Halohydroxamates with Carbon Disulfide to Synthesize Polysubstituted Rhodanines.
Journal: Organic letters
Published: April 08, 2022
The mechanism study of YZG-331 on sedative and hypnotic effects.
Journal: Behavioural brain research
Published: January 25, 2022
Insight into Medicinal Chemistry Behind Traditional Chinese Medicines: p-Hydroxybenzyl Alcohol-Derived Dimers and Trimers from Gastrodia elata.
Journal: Natural products and bioprospecting
Published: June 22, 2020
Discovery, synthesis, and optimization of an N-alkoxy indolylacetamide against HIV-1 carrying NNRTI-resistant mutations from the Isatis indigotica root.
Journal: European journal of medicinal chemistry
Published: November 09, 2019
Structure, property, biogenesis, and activity of diterpenoid alkaloids containing a sulfonic acid group from Aconitum carmichaelii.
Journal: Acta pharmaceutica Sinica. B
Published: October 24, 2019
Gastrodin Derivatives from Gastrodia elata.
Journal: Natural products and bioprospecting
Published: October 14, 2019
Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action.
Journal: Aging
Published: October 01, 2019
Last Updated: 09/26/2026